cas 760150-51-4, Piperidine, 4-(4-ethoxyphenyl)- (9CI)

Articles about 760150-51-4Total 5 be found

Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents
Accumulating evidence has shown multiple roles that chemokine receptor CCR5 may play to promote the progression of several types of cancer. The mechanism of such promotion is believed to involve chronic inflammation that creates a microenvironment which e
Arnatt, Christopher K.,Zaidi, Saheem A.,Zhang, Zhu,Li, Guo,Richardson, Amanda C.,Ware, Joy L.,Zhang, Yan
p. 647 - 658
(2013/10/22)

PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
The invention relates to new piperidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
-
(2013/06/27)

New piperidine derivatives, pharmaceutical compositions and uses thereof
The invention relates to new piperidine derivatives of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
-
(2013/06/26)

NEW PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
The invention relates to new piperidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use as inhibitors of acetyl-CoA carboxylases and to pharmaceutical compositions containing them.
-
(2013/07/05)

Piperidine Derivatives
Piperidine derivatives of which the following is exemplary and their use in the treatment of obesity, diabetes or dyslipidemia.
-
(2013/07/05)